When DTC Testing Isn't Enough | GenomeWeb

In a guest post at the Genomes Unzipped blog, two researchers from the University of California, Berkeley, discuss how genotype imputation could help consumers get more information out of their 23andMe testing results by predicting or "imputing" variants that are not assayed by the genotyping chip.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.